These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37657507)

  • 41. Application of a kosmotrope-based solubility assay to multiple protein therapeutic classes indicates broad use as a high-throughput screen for protein therapeutic aggregation propensity.
    Yamniuk AP; Ditto N; Patel M; Dai J; Sejwal P; Stetsko P; Doyle ML
    J Pharm Sci; 2013 Aug; 102(8):2424-39. PubMed ID: 23712759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
    Mitragotri S; Burke PA; Langer R
    Nat Rev Drug Discov; 2014 Sep; 13(9):655-72. PubMed ID: 25103255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical factors of bioprocessing impact the stability of therapeutic proteins.
    Pandey LM
    Biotechnol Adv; 2022; 55():107909. PubMed ID: 35031395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Different Perspective: How Much Innovation Is Really Needed for Monoclonal Antibody Production Using Mammalian Cell Technology?
    Kelley B; Kiss R; Laird M
    Adv Biochem Eng Biotechnol; 2018; 165():443-462. PubMed ID: 29721583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products.
    Falkenberg H; Waldera-Lupa DM; Vanderlaan M; Schwab T; Krapfenbauer K; Studts JM; Flad T; Waerner T
    Biotechnol Prog; 2019 May; 35(3):e2788. PubMed ID: 30767403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biopharmaceuticals from microorganisms: from production to purification.
    Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of protein cryoconcentration and processing conditions on kinetics of dimer formation for a monoclonal antibody: A case study on bioprocessing.
    Mehta SB; Subramanian S; D'Mello R; Brisbane C; Roy S
    Biotechnol Prog; 2019 Jul; 35(4):e2836. PubMed ID: 31063635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation.
    Castro LS; Lobo GS; Pereira P; Freire MG; Neves MC; Pedro AQ
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NIIMBL-Facilitated Active Listening Meeting between Industry and FDA Identifies Common Challenges for Adoption of New Biopharmaceutical Manufacturing Technologies.
    Mantle JL; Lee KH
    PDA J Pharm Sci Technol; 2020; 74(5):497-508. PubMed ID: 32467179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HP-β-CD for the formulation of IgG and Ig-based biotherapeutics.
    Wu HH; Garidel P; Michaela B
    Int J Pharm; 2021 May; 601():120531. PubMed ID: 33775727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.
    Vass P; Démuth B; Hirsch E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Nagy ZK; Marosi G
    J Control Release; 2019 Feb; 296():162-178. PubMed ID: 30677436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2D and 3D inkjet printing of biopharmaceuticals - A review of trends and future perspectives in research and manufacturing.
    Evans SE; Harrington T; Rodriguez Rivero MC; Rognin E; Tuladhar T; Daly R
    Int J Pharm; 2021 Apr; 599():120443. PubMed ID: 33675921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reducing biopharmaceutical manufacturing costs through continuous processing in a flexible J.POD® facility.
    Garcia FA; Gefroh E
    Drug Discov Today; 2023 Jul; 28(7):103619. PubMed ID: 37201779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins.
    van Beers MM; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1473-84. PubMed ID: 23027660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.
    Vermeer NS; Straus SM; Mantel-Teeuwisse AK; Domergue F; Egberts TC; Leufkens HG; De Bruin ML
    Drug Saf; 2013 Aug; 36(8):617-25. PubMed ID: 23771794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid and disposable facilities for manufacturing of biopharmaceuticals: pros and cons.
    Ravisé A; Cameau E; De Abreu G; Pralong A
    Adv Biochem Eng Biotechnol; 2009; 115():185-219. PubMed ID: 19623478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defining and characterizing the late-stage biopharmaceutical pipeline.
    Nagle PC; Lugo TF; Nicita CA
    Am J Manag Care; 2003 Oct; 9(6 Suppl):S124-35. PubMed ID: 14577717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.